In Real-time PCR, Respiratory infections, Virology

On December 31st, 2019, the World Health Organization (WHO) was informed of several cases of severe pneumonia in the Chinese metropolis of Wuhan City, caused by a previously unknown virus.

On January 30th 2020 the WHO declares the novel coronavirus 2019-nCoV as a global health emergency. Currently more than 7818 cases were confirmed worldwide (7736 in China).

R-Biopharm is currently developing a real-time RT-PCR test for the detection of the new novel coronavirus species 2019-nCoV.

Significant resources have been allocated to make the RIDA®GENE Novel Coronavirus 2019 RUO available within 3 weeks.

Key features of the coming RIDA®GENE Novel Coronavirus 2019 RUO test:

  • Real-time multiplex RT-PCR
  • Time to result: less than 1.5 hours
  • Detection of coronavirus 2019-nCoV
  • Qualitative detection of 2019-nCoV specific RNA from respiratory samples
  • Flexible – the assays can be run on many commonly used real-time PCR instruments, such as the Mx3005P, LightCycler®480II, ABI 7500, CFX96 or Rotor-Gene Q or RIDA®CYCLER
  • Reliable – an included extraction control (Internal control RNA, ICR) detects PCR inhibition, monitors reagent integrity and confirms that nucleic acid extraction was sufficient
  • For research use only

We will update you constantly about the development and the availability of our coming RIDA®GENE Novel Coronavirus 2019 RUO test.

R-Biopharm AG

Recent Posts

Start typing and press Enter to search

RIDA®SEEKNovel Coronavirus Press Release